PAVmed share price logo

PAVmed

NASDAQ: PAVM

$2.87

+0.17

(+6.30%)

as on

PAVmed Stock Performance

as on October 3, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $2.65
    $2.99
    downward going graph

    7.67%

    Downside

    4.18%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.61
    $28.44
    downward going graph

    9.06%

    Downside

    890.94%

    Upside

    downward going graph

PAVmed share price movements today

Previous Close
$2.70
Open
$2.70
Volume
162.9K
Market Cap
$26.6M
Day's Low - High
$2.65 - $2.99
52 Week Low - High
$2.61 - $28.44

PAVmed Historical Returns

1 Month Return
-43.61 %
3 Month Return
-49.74 %
1 Year Return
-78.03 %
3 Year Return
-97.8 %
5 Year Return
-99.92 %

PAVmed Stock Fundamentals & Key Indicators

Check PAVmed market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$26.6M

EPS (TTM)

-16.36

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.17

Industry PE ratio

-3.42

PEG Ratio

0.00

EBITDA

-16.4M

Revenue (TTM)

112.0K

Profit Margin

-254.46%

Return On Equity TTM

-33.51%

PAVmed vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of PAVmed with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
PAVmed image
PAVmed
Buy$26.6M-99.92%-0.17-254.46%0.00%
Edwards Lifesciences image
Edwards Lifesciences
Buy$49.1B-24.16%49.0577.98%0.00%
Medtronic image
Medtronic
Buy$110.4B-32.15%21.1666.69%3.31%
Abbott Laboratories image
Abbott Laboratories
StrongBuy$171.0B-16.82%31.3056.80%2.56%
Stryker image
Stryker
StrongBuy$105.6B2.69%28.1065.17%1.29%
See all

Stock Returns calculator for PAVmed Stock including INR - Dollar returns

The PAVmed stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

PAVmed investment value today

Current value as on today

₹23,844

Returns

-₹76,156

(-76.16%)

Returns from PAVmed Stock

-₹78,033 (-78.03%)

Dollar Impact

₹1,877 (+1.88%)

Analyst Recommendation on PAVmed Stock

Based on 10 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 10 analysts, 80% of analysts recommend a 'BUY' rating for PAVmed. Average target price of $36.5

PAVmed Share Price Target

Get share price movements and forecasts by analysts on PAVmed.

What analysts predicted

92.14%UPSIDE

Target Price

$36.5

Current Price

$2.87

Analyzed by

10 Analysts

Target

$36.50

PAVmed target price $36.5, a slight upside of 92.14% compared to current price of $2.87. According to 10 analysts rating.

Indian Investors' Interest in PAVmed Stock

Search interest for PAVmed Stock has increased by 10% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:10% versus previous 30 day period

PAVmed Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-14
-13
-11
-5
-5
-4
-4
-6
-8
-7
EBITDA
-17
-14
60
1
18
-12
-5
-2
-1
-6
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-18
-14
60
1
18
-12
-6
-2
-1
-6
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-15
-10
64
1
18
-11
-5
-1
0
-5
Net Profit Margin
-72.67%
-101.33%
-38.65%
-380.00%
-887.50%
-583.33%
-1000.00%
-98.08%
-431.82%
-269.70%

PAVmed Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Mar 2019
Mar 2020
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
0
0
2
2
0
Gross Profit
0
0
0
-
0
-3
-3
-3
0
Operating Income
-8
-10
-14
-23
-54
-91
-68
-44
-21
EBITDA
-11
-12
-16
-23
-55
-99
-75
29
-2
Interest Expense
0
2
0
0
-
1
0
0
0
Depreciation
0
0
0
0
0
2
2
1
0
Income Before Tax
-9
-18
-17
-35
-56
-103
-79
28
-2
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-9
-17
-15
-34
-50
-88
-64
39
0
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-17.00%
-858.62%
-161.83%
-101.60%
-354.93%

PAVmed Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-18
-14
60
1
18
-12
-6
-2
-1,064
-6
Operating Cash Flow
-13
-11
-8
0
-1
-1
0
-1
-2,620
-2
Investing Cash Flow
0
0
-16
0
0
0
0
0
-22
0
Financing Cash Flow
19
11
0
0
3
2
0
-
7,564
-
Change in Cash
5
0
-24
0
1
1
0
-1
4,922
-2

PAVmed Annual Cash Flow

All numbers in Millions USD

Dec 2017
Mar 2019
Mar 2020
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-9
-18
-17
-35
-56
-103
-79
28
-2,469
Operating Cash Flow
-6
-8
-13
-21
-40
-70
-52
-33
-5,206
Investing Cash Flow
0
0
0
0
-3
-4
0
-16
-31
Financing Cash Flow
7
15
11
33
104
38
31
31
5,590
Change in Cash
0
6
-2
11
60
-37
-20
-18
353

Global Institutional Holdings in PAVmed

Check out the Institutions with significant holdings in PAVmed.

Funds
Holdings
Vanguard
0.79%
iShares
0.16%
Victory Portfolios III
0.11%
Fidelity Concord Street Trust
0.08%
VANGUARD INDEX FUNDS
0.07%

Insights on PAVmed

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 22.0K → 33.0K (in $), with an average increase of 33.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Edwards Lifesciences Corp has given 22.3% return, outperforming this stock by 120.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 10.5% return, outperforming this stock by 88.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -60.0K → -5.38M (in $), with an average decrease of 8873.3% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, PAVM stock has moved down by -25.4%

About PAVmed

PAVmed Inc. operates as a U.S.-based medical technology firm. Its principal commercialized products include CarpX, a percutaneous device designed to address carpal tunnel syndrome. Other key offerings are EsoCheck, an esophageal cell collection device vital for the early detection of esophageal adenocarcinoma and Barrett's Esophagus (BE), and EsoGuard, a specialized bisulfite-converted next-generation sequencing DNA assay. The company's extensive development pipeline further encompasses EsoCure, an esophageal ablation device intended to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; and NextFlo, a disposable infusion platform technology. Also in development are the Veris cancer healthcare platform, which features an intelligent vascular port for combined remote monitoring and data analytics, alongside Veris cardiac monitors. Additional innovations include NextVent single-use ventilators, FlexMO medical circulatory support cannulas, DisappEAR resorbable pediatric ear tubes, and Solys for noninvasive glucose monitoring. Established in 2014, the enterprise originally traded as PAXmed Inc. before rebranding to PAVmed Inc. in April 2015. Its corporate headquarters are located in New York, New York.
OrganisationPAVmed
Headquarters360 Madison Avenue, New York City, NY, 10017, US
IndustryMedical - Devices
CEOLishan Aklog

Key Management of PAVmed

Name

Title

Dr. Victoria T. Lee M.D.

Executive Vice President & Chief Medical Officer

Mr. Joseph Virgilio

SVP & Chief Business Officer of Medical Devices

Dr. Lishan Aklog M.D.

Chairman & CEO

Mr. Shaun M. O'Neill M.B.A.

Executive VP & COO

Dr. Suman M. Verma M.D., Ph.D.

Senior VP of Molecular Genetics & Chief Scientific Officer

Dr. Deepika A. Lakhani Ph.D.

Senior VP, Chief Regulatory & Quality Officer

Mr. Dennis M. McGrath C.P.A.

President & CFO

Mr. Michael Adam Gordon

Executive VP, General Counsel & Secretary

Dr. Brian J. deGuzman M.D.

Executive VP, Chief Technology & Compliance Officer

Mr. Matthew Riley

Senior Director of Investor Relations

FAQs

What is PAVmed share price today?

PAVmed share price today is $2.87 as on at the close of the market. PAVmed share today touched a day high of $2.99 and a low of $2.65.

What is the 52 week high and 52 week low for PAVmed share?

PAVmed share touched a 52 week high of $28.44 on and a 52 week low of $2.61 on . PAVmed stock price today i.e. is closed at $2.87,which is 89.91% down from its 52 week high and 9.96% up from its 52 week low.

What is PAVmed's market capitalisation today?

PAVmed market capitalisation is $0.00T as on .

How to invest in PAVmed Stock (PAVM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for PAVmed on INDmoney app. Click on Buy button.

What is the minimum amount required to buy PAVmed Stock (PAVM) from India?

Indian investors can start investing in PAVmed (PAVM) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in PAVmed stock (as per the Rupee-Dollar exchange rate as on ). Based on PAVmed share’s latest price of $2.87 as on October 3, 2026 at 8:45 am IST, you will get 3.4843 shares of PAVmed. Learn more about fractional shares .

What are the returns that PAVmed has given to Indian investors in the last 5 years?

PAVmed stock has given -99.92% share price returns and 28.69% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?